BioLife Solutions
BLFS
82 hedge funds and large institutions have $244M invested in BioLife Solutions in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 18 reducing their positions, and 9 closing their positions.
110% more capital invested
Capital invested by funds: $116M → $244M (+$128M)
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
72% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 18
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
9% more funds holding
Funds holding: 75 → 82 (+7)
1.45% less ownership
Funds ownership: 59.01% → 57.55% (-1.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
+$32.8M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$3.52M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
+$3.25M |
| 4 |
RA
Royce & Associates
New York
|
+$2.74M |
| 5 |
GS
Gagnon Securities
New York
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$3.07M |
| 2 |
SCM
Sandler Capital Management
New York
|
-$2.93M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$2.9M |
| 4 |
RC
Roubaix Capital
Denver,
Colorado
|
-$2.1M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.02M |
BLFS Hedge Fund Activity: Q2 2020 in Review
82 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2020, worth a combined $244M — up 110% from $116M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new BLFS positions and 9 closed out — a net gain of 8 holders — while 31 added to existing stakes and 18 trimmed.
The largest buyer was Casdin Capital, adding an estimated $32.8M. The largest seller was Penn Capital Management, exiting entirely with an estimated $3.07M sold.
- 82 institutional investors held BioLife Solutions (BLFS) as of Q2 2020, up from 75 in Q1 2020.
- Funds reported $244M of BioLife Solutions stock for Q2 2020, up 110% quarter-over-quarter.
- 17 funds opened new BioLife Solutions positions in Q2 2020 and 9 closed out, a net change of +8 holders.
- The largest BioLife Solutions buyer in Q2 2020 was Casdin Capital, an estimated $32.8M added.
- The largest BioLife Solutions seller in Q2 2020 was Penn Capital Management, an estimated $3.07M sold.
Based on aggregated 13F filings for Q2 2020.